Article
Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3.
Molecular immunology - 1 Jan 2003
Sahu Arvind, Morikis Dimitrios, Lambris John D
Abstract excerpt
Although activation of complement protein C3 is essential for the generation of normal inflammatory responses against pathogens, its unregulated activation during various pathological conditions leads to host cell damage. Previously we have identified a 13-residue cyclic peptide, Compstatin, that inhibits C3 activation. In this study, we have examined the species-specificity of Compstatin. Bimolecular interaction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
